USPTO 2015–2025 USPTO PatentsView US Corporation

Buckman Laboratories International, Inc.

USPTO PatentsView assignee record - 35 granted patents across 46 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: D21H (PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERW).

35
Total patents granted
46
CPC technology areas
20.3
Avg claims per patent
-16%
5-year filing velocity

The verdict

Buckman holds 35 US patents across 46 technology areas, rank #8,993 of 50,000 tracked assignees.

#8,993
of 50,000 US assignees by volume
Top 6%
by Innovation Score (56.9/100)
20.3
avg claims per patent
-16%
filing velocity, last 5 yrs

Portfolio overview

Buckman Laboratories International, Inc. has been granted 35 US utility patents between 2015 and 2025, placing Buckman Laboratories International, Inc. at rank #8,993 across all assignees tracked by PlainPatent. This portfolio spans 46 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.3 claims per patent with primary concentration in D21H (PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERW). As a US Corporation, Buckman Laboratories International, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Buckman sits between Biodesix, Inc. (35 patents, rank #8,989) and CFD Research Corporation (35 patents, rank #8,997) - the closest US assignees by grant volume. The composite Innovation Score of 56.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 16 grants, compared with 19 in the 2015–2019 window, a -16% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Buckman Laboratories International, Inc.'s 20.3 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 46 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Buckman Laboratories International, Inc. against peers pursuing similar technology classes.

Who files at Buckman's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Buckman holds 35 patents at rank #8,993, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Buckman

By rank, the assignees closest to #8,993 in granted patent volume.

Leaders in D21H (PULP Compositions)

Other assignees with the most granted patents in Buckman's primary technology class.

Buckman's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20152016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Buckman Laboratories International, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 8.6%
2016 5 14.3%
2017 5 14.3%
2018 3 8.6%
2019 3 8.6%
2020 2 5.7%
2021 3 8.6%
2022 2 5.7%
2023 5 14.3%
2024 3 8.6%
2025 1 2.9%

Which technologies does Buckman Laboratories International, Inc. patent most?

Top 15 of 46 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Multi-domain
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#8,993

Across all tracked assignees

Innovation Score

56.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Buckman Laboratories International, Inc. hold?
Buckman Laboratories International, Inc. holds 35 US granted patents filed between 2015 and 2025, spanning 46 technology areas.
What is Buckman Laboratories International, Inc.'s Innovation Score?
Buckman Laboratories International, Inc. has an Innovation Score of 56.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Buckman Laboratories International, Inc. focus on?
Buckman Laboratories International, Inc.'s top technology area is D21H (PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR) with 13 patents. The company has filed patents in 46 CPC subclasses total.
Is Buckman Laboratories International, Inc.'s patent filing rate increasing or decreasing?
Buckman Laboratories International, Inc.'s recent filing velocity is -16% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Buckman Laboratories International, Inc.'s patents?
Buckman Laboratories International, Inc.'s patents average 20.3 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Buckman Laboratories International, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Buckman's 35 grants land it in the top 6% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Buckman ranks #8,993 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in D21H - see who else leads that technology area. D21H leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.